SOPHIA EBENEZER to Cyclin-Dependent Kinase Inhibitor p57
This is a "connection" page, showing publications SOPHIA EBENEZER has written about Cyclin-Dependent Kinase Inhibitor p57.
Connection Strength
0.027
-
Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia. Blood. 2003 May 15; 101(10):4131-6.
Score: 0.027
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.